IMU Ann: Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia - 23rd Mar 2022, 9:54am

annb0t

annb0t

Top 20
IMU Ann: Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia
Price Sensitive: Y
Date: 23rd Mar 2022, 9:54am

>>> Read announcement: Google: IMU Market Announcements
 
  • Like
Reactions: 1 users
You must log in or register to reply here.

Similar threads

annb0t
IMU Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens - 26th Oct 2023, 9:08am
Replies
0
Views
109
annb0t
annb0t
annb0t
IMU Ann: Imugene Appoints Dr John Byon as SVP Clinical Development - 1st Sep 2023, 10:52am
Replies
0
Views
82
annb0t
annb0t
annb0t
IMU Ann: New Dose Escalation in Phase I Clinical Trial of CHECKvacc - 7th Jul 2023, 8:56am
Replies
0
Views
96
annb0t
annb0t
annb0t
IMU Ann: Dose escalates In Phase I Clinical Trial of New Oncolytic Vi - 11th Nov 2022, 11:04am
Replies
0
Views
165
annb0t
annb0t
annb0t
IMU Ann: First patient IV dosed in VAXINIA Phase 1 clinical trial - 21st Sep 2022, 9:29am
Replies
1
Views
243
alwaysgreen
alwaysgreen
Top Bottom